The U.S. Food and Drug Administration (FDA) has now released information regarding import refusals for last month through November 22, 2017. Over the first three weeks of November, the FDA reports that only 1 out of the 62 (1.6%) total seafood entry line refusals were of shrimp for reasons related to banned antibiotics.
The FDA has now reported refusing 70 entry lines of shrimp for reasons related to banned antibiotics in 2017. However, the FDA appears to be revising its reporting on a rolling basis, and the ultimate number of entry lines reported as refused this year may be lower than this total.
The one shrimp entry line refused by the FDA for banned antibiotics in November was from Vietnam:
- Minh Phu Seafood Corporation (Vietnam), a company that was added to Import Alert 16-124 for ciprofloxacin in its shrimp on September 14, 2017, had one entry line refused for shrimp contaminated with veterinary drug residues by the Division of West Coast Imports on November 1, 2017.
Entry lines of shrimp from the Minh Phu Seafood Corporation have been reported as refused for the presence of banned antibiotics in each of the last three months and in seven of the first eleven months of this year. For 2017, Minh Phu Seafood Corporation, on its own, accounts for fully 20 percent of all refusals of shrimp entry lines for antibiotics (14 out of 70). Minh Phu Seafood’s affiliate, Minh Qui Seafood has also had a shrimp entry line refused for antibiotics this year and Minh Phu has had another, additional shrimp entry line refused for the presence of an unsafe additive.